Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.
about
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data reviewAntiepileptic drug monotherapy for epilepsy: a network meta-analysisTopiramate versus carbamazepine monotherapy for partial onset seizures or generalized onset tonic-clonic seizures with or without other generalized seizure typesTopiramate versus carbamazepine monotherapy for partial onset seizures or generalized onset tonic-clonic seizures with or without other generalized seizure typesThe SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialOutcomes of sustained-release formulation of valproate and topiramate monotherapy in patients with epilepsy: a multi-centre, cohort studyTopiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.Cognitive Effects of Low-dose Topiramate Compared with Oxcarbazepine in Epilepsy PatientsReview of topiramate for the treatment of epilepsy in elderly patients.New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.Topiramate hyperpolarizes and modulates the slow poststimulus AHP of rat olfactory cortical neurones in vitro.New drugs for the treatment of epilepsy: a practical approachPharmacokinetic-pharmacodynamic modelling of intravenous and oral topiramate and its effect on phonemic fluency in adult healthy volunteers.Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs.Topiramate for the treatment of epilepsy and other nervous system disorders.Topiramate and its clinical applications in epilepsy.Role of valproate across the ages. Treatment of epilepsy in adults.The treatment of juvenile myoclonic epilepsy.Long-term effect of antiepileptic drug switch on serum lipids and C-reactive proteinTopiramate in the treatment of partial and generalized epilepsy.Evaluation and registration of adverse events in clinical drug trials in migraine.Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care.Transitional polytherapy: tricks of the trade for monotherapy to monotherapy AED conversions.Truly "rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects.Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years: 4-year follow-upPharmacokinetic-Pharmacodynamic Modeling of Intravenous and Oral Topiramate and Its Effect on the Symbol-Digit Modalities Test in Adult Healthy Volunteers.The use of recently approved antiepileptic drugs: use with caution, use in refractory patients or use as first-line indications?Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.The long-term safety of antiepileptic drugs.Weight change, genetics and antiepileptic drugs.The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy.Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.Topiramate for Treatment in Patients With Migraine and Epilepsy.Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.Seizure recurrence and remission after switching antiepileptic drugs.
P2860
Q24186683-1F140B0C-4721-4FAC-B30E-CB509BDEABB7Q24187678-349F9749-8402-44E7-B661-CD915118F5A2Q24187873-F0745077-CBEE-40DE-B565-B442FE3808A6Q24236016-AEE51D2C-B925-4276-A58A-737B0C0F438DQ24676550-899064DE-F914-485B-A193-F3BE986484FAQ28484278-C7B24FCA-BD98-4E68-8833-EF0E6A4D02E4Q31147165-D3C0E7FD-F8BD-4623-A7AC-4530C5928703Q33202108-13F4E76C-ADF2-4F79-B79C-A6E4EA355D65Q33252737-1A86E38B-B1FF-4343-8893-653D879BAFD9Q33790784-5A436B2D-D99D-44D4-A394-20B3A15131C7Q33819386-D1C2C0AF-89A9-4184-A8FE-DE0DABBC7F43Q33949491-F27B9A7C-8152-429E-9DBD-01D2A8DC8C96Q34158012-32EFE262-1ED2-492B-A092-C35975402CF1Q34611908-F8C1F071-1CDC-4920-803A-8C778F627DF1Q35046075-C1955D86-3D33-4BC3-87CA-C6B1A80FA1A9Q35520425-EAA2E721-96C2-4FE4-862D-6CF07E3A69C5Q35557445-70DB754A-DF26-4E0D-9F90-6288E32309DBQ36319439-6C32325B-3F8A-47A7-BA7E-3BA347A400F0Q36390841-CEA08FE8-3281-45D9-B77B-B72C21E0B832Q36429751-BBCE069C-653C-4CA6-B3CF-DA018100A525Q36507535-C8DEC747-C663-417B-9763-E0A48DC3BFF7Q36511305-CAF44012-8A1C-4AFC-BB2E-26AE4E449481Q36923858-93C24A32-89A8-4565-BF9D-78774FBF4B5DQ37129817-1ECAF2DC-7CA3-4BE9-9EAB-41065E35BC18Q37170988-4C3E0D6F-39F3-4D63-93BE-3C42EA44A8B1Q37313439-B1425E77-2C5D-4210-A7D6-735BD1280C7FQ37313452-D54297AC-AB52-4D7E-BEBB-2EAB26D69346Q37313454-9FEA8E4D-608E-43E1-96C2-BDD83ACADB9AQ37417933-84643A81-2759-48C2-A3FC-50CFB1593805Q37666090-C56750C5-C5A3-4094-9CA3-AAB8FDF17B5FQ37957129-9B89E2C7-C758-48D2-B5C4-563F111E43A7Q38076740-C03FDF33-2D7A-4B14-8FD6-919C8EBF910DQ38106856-F96692ED-1FFD-45E9-BB9E-90AAF0DBD551Q38168942-7932E984-96E2-4C90-A26A-720D51290E0DQ38505575-6B55C3D5-EDD9-4056-A23C-C7F1ACEFF884Q38702913-5E8BECC8-AB4A-4F68-A896-50372696B8CFQ38819478-5D81D1F8-FFE5-4562-8A28-3F8394E862A4Q38990303-F5AB0C9D-C9EE-417B-B444-F9C2DDB4A88FQ42164457-F00A5E32-6786-4EC6-8AB6-6732C7C3CB4BQ42283904-92856AF8-546F-4C59-BAD7-6A171761AC32
P2860
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Topiramate, carbamazepine and ...... n in newly diagnosed epilepsy.
@en
Topiramate, carbamazepine and ...... n in newly diagnosed epilepsy.
@nl
type
label
Topiramate, carbamazepine and ...... n in newly diagnosed epilepsy.
@en
Topiramate, carbamazepine and ...... n in newly diagnosed epilepsy.
@nl
prefLabel
Topiramate, carbamazepine and ...... n in newly diagnosed epilepsy.
@en
Topiramate, carbamazepine and ...... n in newly diagnosed epilepsy.
@nl
P2093
P2860
P1476
Topiramate, carbamazepine and ...... n in newly diagnosed epilepsy.
@en
P2093
D W Chadwick
EPMN 105 Study Group
M D Privitera
M J Brodie
R H Mattson
P2860
P304
P356
10.1034/J.1600-0404.2003.00093.X
P407
P577
2003-03-01T00:00:00Z